134 related articles for article (PubMed ID: 7360703)
1. [Sensitivity of hospital strains of Staphylococcus aureus to lincomycin and clindamycin].
Jakubicz P; Dzierzanowska D
Pol Tyg Lek; 1980 Feb; 35(8):269-71. PubMed ID: 7360703
[No Abstract] [Full Text] [Related]
2. [In-vitro activity of clindamycin and lincomycin in the presence of Staphylococcus aureus].
Wiedemann B
Fortschr Med; 1984 Jun; 102(21):603-4. PubMed ID: 6469163
[No Abstract] [Full Text] [Related]
3. Cellular uptake of clindamycin and lincomycin.
Easmon CS; Crane JP
Br J Exp Pathol; 1984 Dec; 65(6):725-30. PubMed ID: 6498086
[TBL] [Abstract][Full Text] [Related]
4. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
5. [Antibacterial activity of clindamycin and lincomycin in broth, serum, and in combination with polymorphonuclear leukocytes against Staphylococcus aureus and Staphylococcus epidermidis].
Bassler M; Just HM; Richter A; Zeller H; Daschner F
Infection; 1984; 12(4):280-5. PubMed ID: 6490174
[TBL] [Abstract][Full Text] [Related]
6. [Lincomycin effects against hospital strains of Staphylococcus aureus].
Jakubicz P; Perkowski H
Wiad Lek; 1973 Feb; 26(3):209-13. PubMed ID: 4689471
[No Abstract] [Full Text] [Related]
7. [Constitutive and inducible clindamycin resistance among nosocomially acquired staphylococci].
Dizbay M; Günal O; Ozkan Y; Ozcan Kanat D; Altunçekiç A; Arman D
Mikrobiyol Bul; 2008 Apr; 42(2):217-21. PubMed ID: 18697419
[TBL] [Abstract][Full Text] [Related]
8. Different kinetic of enzymatic inactivation of lincomycin and clindamycin in Staphylococcus aureus.
Barcs I
J Chemother; 1993 Aug; 5(4):215-22. PubMed ID: 8229148
[TBL] [Abstract][Full Text] [Related]
9. Can interchangeability of lincosamides be assumed in clinical practice? Comparative MICs of clindamycin and lincomycin for Streptococcus pyogenes, Streptococcus agalactiae and Staphylococcus aureus.
Porter MC; Henderson BA; Healy PE; Coombs GW; Ingram PR; McLellan D; Clark B
J Antimicrob Chemother; 2014 Mar; 69(3):856-7. PubMed ID: 24164721
[No Abstract] [Full Text] [Related]
10. Two new types of resistance to lincomycin in pathogenic staphylococci from animals.
Devriese LA
Ann Microbiol (Paris); 1980; 131B(3):261-6. PubMed ID: 7469255
[TBL] [Abstract][Full Text] [Related]
11. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital.
Schreckenberger PC; Ilendo E; Ristow KL
J Clin Microbiol; 2004 Jun; 42(6):2777-9. PubMed ID: 15184468
[TBL] [Abstract][Full Text] [Related]
12. [Inducibility of 1-step and multi-step resistance in Staphylococcus aureus strains].
Cusumano V; Focà A; Zamboni C
G Ital Chemioter; 1977; 24(1-2):113-6. PubMed ID: 615753
[No Abstract] [Full Text] [Related]
13. Microbial kinetics of drug action against gram-positive and gram-negative organisms. III: Effect of lincomycin and clindamycin combinations on Staphylococcus aureus and Escherichia coli.
Heman-Ackah SM
J Pharm Sci; 1975 Oct; 64(10):1621-6. PubMed ID: 1102659
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of lincomycin against Staphylococcus aureus].
Naumann G
Zahn Mund Kieferheilkd Zentralbl; 1986; 74(4):337-41. PubMed ID: 2944315
[No Abstract] [Full Text] [Related]
15. [Clinical microbiology of lincomycin antibiotics].
Modde H
Fortschr Med; 1973 May; 91(15):677-82. PubMed ID: 4145081
[No Abstract] [Full Text] [Related]
16. Clindamycin as an anti-staphylococcal agent--indications and limitations.
Hedström SA
Scand J Infect Dis Suppl; 1984; 43():62-6. PubMed ID: 6598522
[TBL] [Abstract][Full Text] [Related]
17. Possible role of lincomycin-therapy in the genetic alteration of a staphylococcus epidemic population.
Barcs I; Dobronyi I
Acta Microbiol Hung; 1984; 31(3):173-8. PubMed ID: 6516785
[TBL] [Abstract][Full Text] [Related]
18. Erythromycin-induced resistance to clindamycin in Staphylococcus aureus.
Marr JK; Lim AT; Yamamoto LG
Hawaii Med J; 2005 Jan; 64(1):6-8. PubMed ID: 15751751
[TBL] [Abstract][Full Text] [Related]
19. A preliminary in vitro study on inducible and constitutive clindamycin resistance in Staphylococcus aureus from a South Indian tertiary care hospital.
Navaneeth BV
Int J Infect Dis; 2006 Mar; 10(2):184-5. PubMed ID: 16290013
[No Abstract] [Full Text] [Related]
20. Use of the D-test to determine the prevalence of inducible clindamycin-resistant Staphylococcus aureus in a Northern Territory hospital.
Pimentel JD; Lum GD
Pathology; 2006 Jun; 38(3):258-9. PubMed ID: 16753750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
